Mark Schneyer
Vermögen: 1 Mio $ am 30.09.2026
Vermögen: 1 Mio $ am 30.09.2026
Mark C.
Schneyer is Chief Financial Officer & Executive Vice President at ACADIA Pharmaceuticals, Inc. since 2021.
Previously, Mr. Schneyer was Vice President-Business Development at Pfizer Inc. from 2019 to 2020.
Mr. Schneyer completed undergraduate studies at The Wharton School of the University of Pennsylvania in 1996.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 06.08.2026 | 67.828 ( 0,04 % ) | 1 Mio $ | 30.09.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Finanzdirektor/CFO | 10.09.2021 |
| Unternehmen | Position | Ende |
|---|---|---|
| PFIZER INC. | Corporate Officer/Principal | 01.05.2020 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 3 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
ACADIA Pharmaceuticals, Inc.
ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen